Pharma Mar SA
Lara joined PharmaMar in December 2021, having previously developed her professional career in the field of corporate communications at Grupo DIA, where she headed the Communications and External Relations Department. She has extensive experience in the Media, such as CNN+, Cuatro and Actualidad Económica, as a specialist in economic and financial information. She holds a degree in Journalism from the Universidad Complutense in Madrid, the last two years of which she studied at L'Université Paris VIII Vincennes Saint-Denis. She has also completed Management and Communication programs at the IE Business School and on the subject of the EU at the College of Europe.
This person is not in any teams
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.